231 related articles for article (PubMed ID: 2185907)
1. Pharmacokinetics and metabolism of mitoxantrone. A review.
Ehninger G; Schuler U; Proksch B; Zeller KP; Blanz J
Clin Pharmacokinet; 1990 May; 18(5):365-80. PubMed ID: 2185907
[TBL] [Abstract][Full Text] [Related]
2. Mitoxantrone: a review of its use in multiple sclerosis.
Scott LJ; Figgitt DP
CNS Drugs; 2004; 18(6):379-96. PubMed ID: 15089110
[TBL] [Abstract][Full Text] [Related]
3. Clinical pharmacology of mitoxantrone.
Ehninger G; Proksch B; Heinzel G; Woodward DL
Cancer Treat Rep; 1986 Dec; 70(12):1373-8. PubMed ID: 3791250
[TBL] [Abstract][Full Text] [Related]
4. New aspects on the pharmacokinetics of mitoxantrone and its two major metabolites.
Schleyer E; Kamischke A; Kaufmann CC; Unterhalt M; Hiddemann W
Leukemia; 1994 Mar; 8(3):435-40. PubMed ID: 8127148
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of mitoxantrone in cancer patients treated by high-dose chemotherapy and autologous bone marrow transplantation.
Richard B; Launay-Iliadis MC; Iliadis A; Just-Landi S; Blaise D; Stoppa AM; Viens P; Gaspard MH; Maraninchi D; Cano JP
Br J Cancer; 1992 Mar; 65(3):399-404. PubMed ID: 1558794
[TBL] [Abstract][Full Text] [Related]
6. Mitoxantrone: a novel anthracycline derivative.
Koeller J; Eble M
Clin Pharm; 1988 Aug; 7(8):574-81. PubMed ID: 3048848
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic and pharmacodynamic studies with mitoxantrone in the treatment of patients with nasopharyngeal carcinoma.
Hu OY; Chang SP; Law CK; Jian JM; Chen KY
Cancer; 1992 Feb; 69(4):847-53. PubMed ID: 1735075
[TBL] [Abstract][Full Text] [Related]
8. Excretion and metabolism of mitoxantrone in rabbits.
Richard B; Fabre G; Fabre I; Cano JP
Cancer Res; 1989 Feb; 49(4):833-7. PubMed ID: 2912555
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of mitoxantrone in man and laboratory animals.
Batra VK; Morrison JA; Woodward DL; Siverd NS; Yacobi A
Drug Metab Rev; 1986; 17(3-4):311-29. PubMed ID: 3552542
[TBL] [Abstract][Full Text] [Related]
10. Phase I clinical and pharmacokinetic evaluation of high-dose mitoxantrone in combination with cytarabine in patients with acute leukemia.
Feldman EJ; Alberts DS; Arlin Z; Ahmed T; Mittelman A; Baskind P; Peng YM; Baier M; Plezia P
J Clin Oncol; 1993 Oct; 11(10):2002-9. PubMed ID: 8410125
[TBL] [Abstract][Full Text] [Related]
11. [Pharmacokinetic study of mitoxantrone].
Ogawa M; Sampi K; Tsukui T; Oguro M; Sakai K
Gan To Kagaku Ryoho; 1986 Oct; 13(10):3028-33. PubMed ID: 3767389
[TBL] [Abstract][Full Text] [Related]
12. The pharmacokinetics and metabolism of mitoxantrone in man.
Ehninger G; Proksch B; Heinzel G; Schiller E; Weible KH; Woodward DL
Invest New Drugs; 1985; 3(2):109-16. PubMed ID: 4019115
[TBL] [Abstract][Full Text] [Related]
13. Plasma and cellular pharmacokinetics of mitoxantrone in high-dose chemotherapeutic regimen for refractory lymphomas.
Canal P; Attal M; Chatelut E; Guichard S; Huguet F; Muller C; Schlaifer D; Laurent G; Houin G; Bugat R
Cancer Res; 1993 Oct; 53(20):4850-4. PubMed ID: 8402672
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic studies of mitoxantrone and one of its metabolites in serum and urine in patients with advanced breast cancer.
Rentsch KM; Schwendener RA; Pestalozzi BC; Sauter C; Wunderli-Allenspach H; Hänseler E
Eur J Clin Pharmacol; 1998 Mar; 54(1):83-9. PubMed ID: 9591936
[TBL] [Abstract][Full Text] [Related]
15. Human central nervous system and plasma pharmacology of mitoxantrone.
Green RM; Stewart DJ; Hugenholtz H; Richard MT; Thibault M; Montpetit V
J Neurooncol; 1988; 6(1):75-83. PubMed ID: 3397768
[TBL] [Abstract][Full Text] [Related]
16. Mitoxantrone: bluebeard for malignancies.
van der Graaf WT; de Vries EG
Anticancer Drugs; 1990 Dec; 1(2):109-25. PubMed ID: 2151849
[TBL] [Abstract][Full Text] [Related]
17. Escalating dose regimen of intraperitoneal mitoxantrone: phase I study--clinical and pharmacokinetic evaluation.
Blöchl-Daum B; Eichler HG; Rainer H; Jakesz R; Salzer H; Steger G; Schüller J; Günther E; Proksch B; Ehninger G
Eur J Cancer Clin Oncol; 1988 Jul; 24(7):1133-8. PubMed ID: 3416898
[TBL] [Abstract][Full Text] [Related]
18. Clinical pharmacokinetics of vinorelbine.
Levêque D; Jehl F
Clin Pharmacokinet; 1996 Sep; 31(3):184-97. PubMed ID: 8877249
[TBL] [Abstract][Full Text] [Related]
19. Pharmacology of mitoxantrone: mode of action and pharmacokinetics.
Alberts DS; Peng YM; Bowden GT; Dalton WS; Mackel C
Invest New Drugs; 1985; 3(2):101-7. PubMed ID: 4040505
[TBL] [Abstract][Full Text] [Related]
20. A clinical and pharmacokinetic study of mitoxantrone in acute nonlymphocytic leukemia.
Larson RA; Daly KM; Choi KE; Han DS; Sinkule JA
J Clin Oncol; 1987 Mar; 5(3):391-7. PubMed ID: 3546616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
